Welcome Guest | Register / Login

Therapeutic Market Research Reports

Sort By
Title Published Price
Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review
By GlobalData
Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb...
Jun 2021 $ 125
Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb...
Jun 2021 $ 125
Coronavirus Disease 2019 (COVID-19) Clinical Trials - Overview, Landscape, Trial using Vaccines vs. Therapeutics,and Trials Impacted by COVID-19
By GlobalData
Coronavirus Disease 2019 (COVID-19) Clinical Trials - Overview, Landscape, Trial using Vaccines vs. Therapeutics,and Trials Impacted by COVID-19 Summary This report provides an overview of global COVID-19 clinical trials ext...
May 2021 $ 695
Trillium Therapeutics Inc (TRIL) - Financial and Strategic SWOT Analysis Review
By GlobalData
Trillium Therapeutics Inc (TRIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un...
May 2021 $ 125
Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbia...
May 2021 $ 125
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an ...
May 2021 $ 125
PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review
By GlobalData
PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiase...
May 2021 $ 125
Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and a...
Apr 2021 $ 125
Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbias...
Apr 2021 $ 125
United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review
By GlobalData
United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb...
Apr 2021 $ 125
Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review
By GlobalData
Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbias...
Apr 2021 $ 125
Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an u...
Apr 2021 $ 125
Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbi...
Apr 2021 $ 125
Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an ...
Apr 2021 $ 125
Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review
By GlobalData
Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased...
Apr 2021 $ 125
Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un...
Apr 2021 $ 125
Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an ...
Apr 2021 $ 125
CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review
By GlobalData
CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb...
Apr 2021 $ 125
Intellia Therapeutics Inc (NTLA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company. It develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases ...
Apr 2021 $ 300
Crescita Therapeutics Inc (CTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Crescita Therapeutics Inc (Crescita Therapeutics) operates as a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company's pr...
Apr 2021 $ 300
DiaMedica Therapeutics Inc (DMA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-1...
Apr 2021 $ 300
Global Blood Therapeutics Inc (GBT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candi...
Apr 2021 $ 300
Knight Therapeutics Inc (GUD) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Knight Therapeutics Inc (Knight Therapeutics) focuses on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. The company offers tablets to treat metabolic, renal disea...
Apr 2021 $ 300
Pluristem Therapeutics Inc (PSTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Pluristem Therapeutics Inc (Pluristem) operates as a clinical-stage biotherapy company that focuses on the development of placental-derived cell therapies. Its PLacental eXpanded (PLX) cells are adherent stromal cells that can be...
Apr 2021 $ 300
Bone Therapeutics SA (BOTHE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. It offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for...
Apr 2021 $ 300
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy